Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunological defenses in CAPD.

S Lamperi1, S Carozzi

  • 1Division of Nephrology, St. Martin's Hospital, Genoa, Italy.

Blood Purification
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Patients on continuous ambulatory peritoneal dialysis (CAPD) with high peritonitis rates show weakened immune defenses. Intraperitoneal IgG and interferon-alpha may offer a novel treatment approach for these individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Two-chamber hemodiafiltration: comparison between exogenous reinfusion (PFD) and endogenous reinfusion (HFR)].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2005
Same author

Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·1997
Same author

Plasma somatostatin response to an oral test meal in liver transplant patients.

Metabolism: clinical and experimental·1997
Same author

Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·1997
Same author

Immunosuppressive effects of different calcium channel blockers in human kidney allografts.

Transplantation proceedings·1995
Same author

Renal transplantation from living donor parents in two brothers with Alport syndrome. Can asymptomatic female carriers of the Alport gene be accepted as kidney donors?

Nephron·1995
Same journal

Could serum CA125 aid the clinical assessment of volume status of end-stage kidney disease patients treated by peritoneal dialysis patients?

Blood purification·2026
Same journal

From Bench to Bedside: Implications and Interventions for Endotoxin Exposure in Lipopolysaccharide-Induced Apoptosis and Eryptosis.

Blood purification·2026
Same journal

Feasibility Study of a Smartphone App and Web Portal for Remote Monitoring of Chronic Kidney Disease and Peritoneal Dialysis populations: A mixed-method study.

Blood purification·2026
Same journal

Treatment of Focal Segmental Glomerulosclerosis in Low- and Middle-Income Countries: Emerging Extracorporeal Therapies.

Blood purification·2026
Same journal

Creatinine Paradox in CRRT: Higher Levels, Lower Mortality - A MIMIC-IV Validation Study.

Blood purification·2026
Same journal

Expanded Home Hemodialysis trial (HHDx): Study Design and Baseline Characteristics of a Pragmatic Real-World Cohort.

Blood purification·2026
See all related articles

Area of Science:

  • Nephrology
  • Immunology
  • Infectious Disease

Background:

  • High peritonitis rates in continuous ambulatory peritoneal dialysis (CAPD) patients suggest compromised peritoneal defense mechanisms.
  • Key immune functions like opsonization, phagocytosis, and bacterial killing may be impaired in susceptible CAPD patients.

Purpose of the Study:

  • To investigate the relationship between peritoneal immune function and peritonitis incidence in CAPD patients.
  • To explore potential therapeutic strategies targeting identified immune defects.

Main Methods:

  • Assessed in vitro opsonization of bacteria and IgG concentration in dialysate.
  • Evaluated macrophage function, including fibronectin production and bactericidal activity.
  • Examined lymphokine and monokine release in CAPD patients with high peritonitis rates.

Related Experiment Videos

Main Results:

  • Peritonitis incidence correlated with dialysate IgG levels and bacterial opsonization.
  • Decreased macrophage bactericidal activity was observed in patients with frequent peritonitis.
  • Impaired lymphokine/monokine release may further reduce macrophage bacterial killing capacity.

Conclusions:

  • Humoral and cellular immune defects contribute to high peritonitis rates in a subgroup of CAPD patients.
  • Intraperitoneal administration of IgG and interferon-alpha presents a potential therapeutic avenue for these patients.